Geftinat Tablet 30 is used to treat non-small-cell lung cancer with susceptible epidermal growth factor receptor (EGFR) mutations. It is a single-ingredient EGFR tyrosine kinase inhibitor containing gefitinib.
Gefitinib blocks EGFR signalling that promotes the growth and spread of susceptible cancer cells, helping slow disease progression.
Before starting, tell your doctor about lung, liver or eye problems and all other medicines you take. Report persistent diarrhoea, severe skin reactions, breathing difficulty or worsening cough promptly. Do not stop taking the medicine unless your doctor advises you to do so.





























































